2-27366943-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001034116.2(EIF2B4):​c.1014-7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,613,664 control chromosomes in the GnomAD database, including 125,907 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 13339 hom., cov: 32)
Exomes 𝑓: 0.39 ( 112568 hom. )

Consequence

EIF2B4
NM_001034116.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00002390
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.513

Publications

31 publications found
Variant links:
Genes affected
EIF2B4 (HGNC:3260): (eukaryotic translation initiation factor 2B subunit delta) Eukaryotic initiation factor 2B (EIF2B), which is necessary for protein synthesis, is a GTP exchange factor composed of five different subunits. The protein encoded by this gene is the fourth, or delta, subunit. Defects in this gene are a cause of leukoencephalopathy with vanishing white matter (VWM) and ovarioleukodystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
GTF3C2-AS2 (HGNC:55699): (GTF3C2 antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-27366943-T-C is Benign according to our data. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-27366943-T-C is described in CliVar as Benign. Clinvar id is 95736.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.48 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2B4NM_001034116.2 linkc.1014-7A>G splice_region_variant, intron_variant Intron 10 of 12 ENST00000347454.9 NP_001029288.1 Q9UI10-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2B4ENST00000347454.9 linkc.1014-7A>G splice_region_variant, intron_variant Intron 10 of 12 1 NM_001034116.2 ENSP00000233552.6 Q9UI10-1

Frequencies

GnomAD3 genomes
AF:
0.411
AC:
62372
AN:
151858
Hom.:
13309
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.486
Gnomad AMI
AF:
0.277
Gnomad AMR
AF:
0.448
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.432
Gnomad MID
AF:
0.370
Gnomad NFE
AF:
0.380
Gnomad OTH
AF:
0.369
GnomAD2 exomes
AF:
0.400
AC:
100371
AN:
250944
AF XY:
0.393
show subpopulations
Gnomad AFR exome
AF:
0.484
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.343
Gnomad EAS exome
AF:
0.154
Gnomad FIN exome
AF:
0.430
Gnomad NFE exome
AF:
0.380
Gnomad OTH exome
AF:
0.391
GnomAD4 exome
AF:
0.387
AC:
566304
AN:
1461688
Hom.:
112568
Cov.:
49
AF XY:
0.386
AC XY:
280656
AN XY:
727148
show subpopulations
African (AFR)
AF:
0.487
AC:
16313
AN:
33476
American (AMR)
AF:
0.544
AC:
24309
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
8969
AN:
26134
East Asian (EAS)
AF:
0.141
AC:
5598
AN:
39664
South Asian (SAS)
AF:
0.401
AC:
34564
AN:
86242
European-Finnish (FIN)
AF:
0.434
AC:
23179
AN:
53378
Middle Eastern (MID)
AF:
0.349
AC:
2013
AN:
5768
European-Non Finnish (NFE)
AF:
0.385
AC:
428558
AN:
1111908
Other (OTH)
AF:
0.378
AC:
22801
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
21704
43408
65113
86817
108521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13632
27264
40896
54528
68160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.411
AC:
62458
AN:
151976
Hom.:
13339
Cov.:
32
AF XY:
0.411
AC XY:
30498
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.486
AC:
20124
AN:
41442
American (AMR)
AF:
0.449
AC:
6856
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1189
AN:
3470
East Asian (EAS)
AF:
0.157
AC:
811
AN:
5168
South Asian (SAS)
AF:
0.403
AC:
1943
AN:
4824
European-Finnish (FIN)
AF:
0.432
AC:
4551
AN:
10532
Middle Eastern (MID)
AF:
0.378
AC:
111
AN:
294
European-Non Finnish (NFE)
AF:
0.380
AC:
25833
AN:
67950
Other (OTH)
AF:
0.373
AC:
787
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1894
3788
5682
7576
9470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.382
Hom.:
16723
Bravo
AF:
0.415
Asia WGS
AF:
0.335
AC:
1165
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28008009) -

Sep 13, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vanishing white matter disease Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
3.6
DANN
Benign
0.41
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000024
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2280737; hg19: chr2-27589810; COSMIC: COSV52011599; COSMIC: COSV52011599; API